Next-generation Sequencing (NGS) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1564 | Report Format : | Status : Upcoming |

Abstract

Global Next-generation Sequencing (NGS) Market: Overview

The next-generation sequencing is also acknowledged as high-throughput sequencing; it includes a number of several sequencing technologies that are new and modern such as Roche 454 sequencing, SOLiD sequencing, Illumina (Solexa) sequencing, and Ion torrent: Proton/PGM sequencing. These advanced technologies help in sequencing the RNA and DNA speedily and this method is cheaper and affordable than the Sanger sequencing method, which was used previously. Thus, next-generation sequencing has revolutionized the study of molecular biology and genomics.

Global Next-generation Sequencing (NGS) Market: Segmentation

The next-generation sequencing market is globally segmented into product and services, technology, application, and end-user. On the basis of product and services, the global market is segregated into pre-sequencing products and services market, sequencing services market, NGS platforms, consumables, reagents, and services, and NGS data analysis, storage, and management (bioinformatics) market. Based on the technology, the market is categorized into ion semiconductor sequencing, nanopore sequencing, sequencing by synthesis (SBS), and single-molecule real-time (SMRT) sequencing. Depending on the application, the market is divided into drug discovery, precision medicine, marine research, forensic medicine, phylogeographic & phylogenetic studies, diagnostics, biomarker discovery, agriculture and animal research, and research in bio-fuels. Based on the end user, the market is fragmented into hospitals & clinics, agrigenomics organizations, research centers, academic & government institutes, NPOS, pharmaceutical & biotechnology companies, and consumer genomic companies

Global Next-generation Sequencing (NGS) Market: Growth Factors

The advancements that are made in the technology vertical of sequencing platforms and the growing number of next-generation sequencing applications will encourage the global next-generation sequencing market growth in the future. Besides, the increasing adoption of the next-generation sequencing technologies in the research laboratories and research academic institutes projects to supplement the improvement of the market in the coming years. Nevertheless, the growing awareness amongst the consumers concerning the advantages of next-generation sequencing with the help of conferences and workshops are contributing to the growth of the market. In contrast, the growing issues such as the lack of skilled professionals and the storage of sequencing data are affecting the market growth negatively.

Global Next-generation Sequencing (NGS) Market: Regional Analysis

The geographical segmentation of the next-generation sequencing market is diversified into Asia-Pacific, Europe, North America, and Rest of the World. The major market share is held by the North American region and will be the same in the coming years. The key factors that are contributing to this market growth are the existence of a large number of market players in the U.S. and the encouraging government schemes. Additionally, Asia Pacific region will grow substantially in the coming few years. Factors that attribute to this regional market growth are the development of the healthcare sector in the emerging nations and the positive initiatives that are taken by the government. Other factors such as the launch of developed and improved next-generation sequencing products and services anticipate contributing considerably towards the market growth.

Global Next-generation Sequencing (NGS) Market: Competitive Players

Some of the key market players that are involved next-generation sequencing market include Gatc Biotech AG, Perkinelmer, Inc., Qiagen N.V., Macrogen, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Ltd., Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina, Inc., Agilent Technologies, Inc., Beijing Genomics Institute, and Thermo Fisher Scientific Inc.

Global Next-generation Sequencing (NGS) Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market

Related Reports

Aseptic Sampling Market by Type (Manual Aseptic Sampling and Automated Aseptic Sampling), by Technique (Off-Line Sampling, At-Line Sampling, and On-Line Sampling), by Application (Upstream Process and Downstream Process), and by End-User (Biotechnology and Pharmaceutical Manufacturers, Contract Research and Manufacturing Organizations, Research and Development Departments, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3916 | Report Format:

The report covers a forecast and an analysis of the aseptic sampling market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the aseptic sampling...Read More

Genotyping Assay Market by Products & Services (Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics), by Technology (PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-Tof MS, and Others), by Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and by End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3874 | Report Format:

The report covers a forecast and an analysis of the genotyping assay market on a global and regional level. The study provides historical data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the genotyping assay m...Read More

Bioburden Testing Market by Product Type (Instrument and Consumables), by Test Type (Anaerobic, Aerobic, Spore, and Fungi), by Application (Sterility Testing, Medical Devices, and Raw Material), and by End-User (Biotechnology, Pharma, and CMO): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Feb-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3869 | Report Format:

The report covers a forecast and an analysis of the bioburden testing market on a global and regional level. The study provides historic data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the bioburden ...Read More

Cancer Biological Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3862 | Report Format:

Global Cancer Biological Therapy Market: Overview Biological cancer therapies use the bodys immune system, either directly or indirectly, to fight cancer or to lessen the side effects that may be caused by some cancer treatments. It is also called biotherapy or biological response modifiers.Biol...Read More

Human Milk Oligosaccharides (HMO) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3837 | Report Format:

Global Human Milk Oligosaccharides (HMO) Market: Overview Human milk oligosaccharides (HMO) is present in human milk in the form of a complex bioactive sugar molecule. HMOs are growth substrates for certain useful bacteria. Extracting or synthesizing HMO in the formula is quite difficult as they...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.